Company News
09/16/2021
Embody, Inc. Appoints New Board Member and Expands Leadership Team
Embody, Inc., a privately held medical device company focused on soft tissue healing, announces new appointments to its board and leadership team following the recently announced growth funding round of $20.5M to support continued commercial growth. The company adds Rene Salas to its Board of Directors. Rene is a 30-year life science veteran and previously …
09/16/2021
Fralin Biomedical Research Institute spinoff Tiny Cargo Co. among Washington, DC Health Innovation QuickFire Challenge awardees
Tiny Cargo Co., a biotech startup founded by Rob Gourdie, professor at the Fralin Biomedical Research Institute at VTC, is among five companies to receive a Washington, DC Health Innovation QuickFire Challenge award. Spencer Marsh, a postdoctoral researcher in Gourdie’s laboratory, presented the pitch that awarded the company $50,000, the opportunity to reside at JLABS @ Washington, D.C. with …
09/02/2021
ATCC Expands Board of Directors With Three Appointments
ATCC, the world’s premier biological materials management and standards organization, announced that Dr. Melissa Rewolinski, Steve Curts and Heather Kiessling have joined its board of directors. ATCC’s board helps advise the senior leadership team on a variety of business, strategy and science-related issues. Board members work closely with management to identify new opportunities to deepen …
09/01/2021
ISOThrive Awarded Composition of Matter and Production Method Patent for its First “Farmaceutical™” to Support Animal Health
ISOThrive Inc., a microbiome therapeutics company announced that the U.S. Patent and Trademark Office has issued a Composition of Matter and Production Method patent for its first Farmaceutical™ Maltosyl-Isomaltooligosaccharides (MIMO™), a prebiotic for use as an animal feed additive and pet food supplement. USDA and University of GA studies showed MIMO as highly effective at …
08/04/2021
Allulose Patents Granted to Bonumose for Unique Enzymatic Conversion Process
Bonumose is pleased to announce that the U.S. Patent & Trademark Office has issued U.S. Patent No. 11,078,506 for “Enzymatic Production of D-Allulose”. This patent issuance follows Bonumose’s Allulose U.S. Patent No. 11,053,528 (July 6, 2021) and allulose U.S. Patent No. 10,704,069 (July 7, 2020). Bonumose has been issued additional Allulose patents and/or has patent …
08/04/2021
Embody Announces $20.5M Funding Round
Embody, Inc., a privately-held medical device company focused on soft tissue healing, announced that it has secured $11.5 million in an oversubscribed equity financing and entered into a debt financing agreement led by Horizon Technology Finance Corporation to provide up to $9 million in term loans, of which an initial $5 million has been funded, …